Daily non-political popular news in brief.
Disadvantaged TB patients urgently need social support to make medical treatment more effective
05-23-2007 · EurekAlert!TB continues to rise worldwide, but healthcare professionals can't treat the disease effectively if their patients aren't receiving the social support they need. London-based study of 250 TB patients found high percentages of homeless people, asylum seekers and people on low or no income.
Read more »
Keywords: disadvantaged, patients, urgently, social, support, make, medical, treatment, effective, patient
« Previous | Next »
Similar news on "Disadvantaged TB patients urgently need social support to make medical treatment more effective":
- Patient adherence for successful tuberculosis treatment
03-27-2007 · EurekAlert!
Existing treatment against Tuberculosis is effective but long and many patients abandon it before the end or take their doses at excessively long intervals. In order to improve patients' adherence to treatment, IRD researchers are putting the emphasis on adaptation of control strategies to patients' real geographical, social, health and cultural situation. Trials conducted in Senegal showed the effectiveness of such an approach, which should limit the spread of the disease and the emergence of new resistant strains.
Similar news · Read more »
- Study shows cognitive decline is often undetected
10-27-2006 · EurekAlert!
Many patients over the age of 65 who are hospitalized with an acute illness experience a subtle change in their cognitive ability that often goes undiagnosed, untreated and under-reported. As a result, a patient's ability to make decisions about his or her medical treatment may be negatively impacted.
Similar news · Read more »
- Tweaking the treatment for restless legs
12-20-2006 · EurekAlert!
Newly approved medications for restless leg syndrome may only be effective for a time, suggest movement disorder neurologists from the University of Rochester Medical Center. If taken too long, in some cases the drugs can actually backfire, causing symptoms to worsen. Rochester specials suggest that treatment that rotates through different types of medications may be needed for many patients.
Similar news · Read more »
- Asacol treats UC symptoms of isolated proctitis
12-05-2007 · EurekAlert!
Data from two Phase III clinical trials support that Asacol, an oral, nonsteroidal medication that belongs to the class of agents known as 5-aminosalicylic acids, is an effective and well-tolerated treatment for patients with all extents of ulcerative colitis, including isolated proctitis.
Similar news · Read more »
- MRI of the ankle changes patient treatment and improves referring physician confidence in diagnosis
01-05-2007 · EurekAlert!
MR imaging can make a dramatic difference in the management of patients with ankle pain, changing treatment in about one-third of the patients, a new study finds.
Similar news · Read more »
- Cancer care providers need to proactively address patients' psychological and social needs
10-23-2007 · EurekAlert!
Cancer care that focuses solely on eradicating tumors without addressing the patient's general well-being can increase patients' suffering, may compromise their ability to follow through on treatment, and falls short of achieving quality care, says a new report from the Institute of Medicine.
Similar news · Read more »
- Can cholesterol-lowering medicine make radiation more effective at curing prostate cancer?
10-29-2007 · EurekAlert!
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session Oct. 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Similar news · Read more »
- Novel gallium compound may offer treatment for lymphoma patients with resistant disease
12-11-2006 · EurekAlert!
Christopher Chitambar, M.D., a physician researcher at the Medical College of Wisconsin Cancer Center in Milwaukee, has identified a compound that may be effective in treating forms of non-Hodgkin's lymphoma (a cancer of the lymphatic system) that are resistant to certain therapies. The new agent could also offer the advantages of being administered orally, rather than intravenously, making it more convenient than intravenous agents.
Similar news · Read more »
- Due to cost, heart attack patients often avoid follow-up care and medication
03-13-2007 · EurekAlert!
A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine. Published in the March 14 issue of Journal of the American Medical Association (JAMA), the study sought to determine if self-reported financial barriers to health care services or medication were associated with worse patient outcomes.
Similar news · Read more »
- Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
12-20-2007 · EurekAlert!
The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
Similar news · Read more »
